AUSTIN, Texas, Sept. 15, 2020 /PRNewswire/ — Perseus Holdings USA, an immuno-oncology company focused on the development and commercialization of next-generation, immune-mediated technologies for the treatment of cancer, today announced the appointment of Ben “Bud” M. Brigham to its board of directors, effective immediately. Mr. Brigham is a serial entrepreneur with approximately 30 years of executive experience, having founded several enterprises in the energy and real estate sectors, and has participated as an investor across a wide variety of industries. He currently serves as chairman of Anthem Ventures, Brigham Minerals (NYSE: MNRL), Atlas Sand and Brigham Exploration. Brigham Exploration is the namesake for the first company he founded in 1990, which went public in 1997 prior to its sale in 2011.


“We are thrilled for Mr.¬†Brigham to join the board of directors. His experience as an entrepreneur and investor, having raised substantial capital, including successfully taking

Read More